Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Oxygenta Pharmaceutical Ltd (NSE: OXYGENTAPH), ISIN INE102E01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
OXYGENTAPH last traded at ₹50.86 (+0.00%), with a 52-week range of ₹43.00 to ₹71.59 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 56.54%, FIIs 0.00%, DIIs 0.03%, mutual funds 0.03%.
EquiSense Score (ECS): 45/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.